Atossa Therapeutics, Inc. (ATOS): Cash & Equivalents
$41.30M
As of 2025-12-31
$26.09M
As of 2026-06-30
-28.1%
3-year compound annual growth
+0.9%
5-year compound annual growth
+27.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.30M | -41.9% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $71.08M | -19.6% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $88.46M | -20.2% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $110.89M | -18.7% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $136.38M | +244.8% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $39.55M | +214.4% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $12.58M | +21.2% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $10.38M | +43.8% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $7.22M | +138.4% | 2019-03-28, Balance as of period end |
| 2016-12-31 | $3.03M | -18.5% | 2018-03-08, Balance as of period end |
| 2015-12-31 | $3.72M | -56.3% | 2017-03-21, Balance as of period end |
| 2014-12-31 | $8.50M | +34.0% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $6.34M | +267.6% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $1.73M | -9.7% | 2014-03-27, Balance as of period end |
| 2011-12-31 | $1.91M | n/m | 2014-03-27, Balance as of period end |
| 2010-12-31 | $10.3K | n/a | 2013-03-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | 2025-12-31 | $41.30M | -41.9% |
| Akari Therapeutics Plc (AKTX) | 2025-12-31 | $0 | n/a |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $30.15M | -34.9% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $30.79M | -54.1% |
| Unicycive Therapeutics, Inc. (UNCY) | 2025-12-31 | $29.20M | +11.7% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.99M | -41.3% |
| Medicinova Inc (MNOV) | 2025-12-31 | $30.81M | -23.7% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $46.82M | +22.1% |
| NextCure, Inc. (NXTC) | 2025-12-31 | $25.98M | -6.3% |
Compare ATOS, AKTX, VRCA, VTGN side by side · Screen every company in Pharmaceutical Preparations ↗